Related Experiment Video
Updated: Feb 1, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Gerbode defect misinterpreted as pulmonary hypertension
Ruchira Garg1, Richard Garcia1, Robert J Cubeddu2
1Miami Children's Hospital, 3100 S.W. 62nd Avenue, Miami, FL 33155-3009, USA.
Insights
A rare Gerbode defect, a left ventricle-to-right atrium shunt, can be misdiagnosed as pulmonary hypertension in adult congenital heart disease patients. Noninvasive imaging can confirm this diagnosis with high clinical suspicion.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease
- Medical Imaging
Background:
- Adult congenital heart disease (CHD) management presents complex challenges for cardiologists.
- Patients with complex CHD and prior surgeries require specialized care.
- Misdiagnosis of cardiac conditions can occur in adult CHD patients.
Purpose of the Study:
- To highlight the diagnostic challenges of a Gerbode defect in adult CHD.
- To present a case of misdiagnosed pulmonary hypertension due to a Gerbode defect.
- To emphasize the utility of noninvasive imaging in diagnosing Gerbode defects.
Main Methods:
- Case report of a 64-year-old woman with a history of CHD and multiple cardiac surgeries.
- Initial diagnosis via transthoracic echocardiogram suggested pulmonary hypertension and VSD.
- Comprehensive noninvasive evaluation including cardiac MRI confirmed a Gerbode defect.
Main Results:
- A Gerbode defect (left ventricle-to-right atrium shunt) was identified, not severe pulmonary hypertension.
- The high-velocity jet was misinterpreted as tricuspid regurgitation.
- The ventricular septal defect was found to be small and restrictive with normal pulmonary pressures.
Conclusions:
- Gerbode defects can be challenging to diagnose in adult CHD patients.
- Noninvasive imaging strategies, particularly echocardiography and cardiac MRI, are crucial for diagnosis.
- High clinical suspicion combined with advanced imaging can accurately identify Gerbode defects, preventing misdiagnosis.
Abstract:
Survival into adulthood is now routine for patients with congenital heart disease (CHD). Adult cardiology practices increasingly encounter these patients, however, are often challenged by the complexity of the cardiac lesions, prior surgical interventions, and associated conditions. We describe a case of a 64-year-old woman with history of CHD and multiple operations, including surgical aortic valve replacement, who presented for routine evaluation. During transthoracic echocardiogram she was believed to have idiopathic severe pulmonary hypertension (tricuspid regurgitation velocity of 4.6 m/s) and a ventricular septal defect (VSD). Consequently, she was referred to a pediatric CHD center. On noninvasive evaluation it became clear that a flow jet through a Gerbode defect, from left ventricle to right atrium, had led to the initial misdiagnosis of severe pulmonary hypertension. The patient was reassured that the VSD was small, restrictive, and that the pulmonary pressures were normal. <Learning objective: Recognition of a left ventricle-to-right atrial shunt (Gerbode defect) is challenging in the adult congenital heart patient. However, this diagnosis can be made with a noninvasive imaging strategy in the context of a high clinical suspicion: A combination of transthoracic echocardiography and cardiac MRI findings of a high velocity "tricuspid regurgitation jet" but normal appearing right ventricular pressures in someone with prior subaortic membrane and aortic valve surgery led to the diagnosis of a Gerbode defect in our patient.>.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

